Keyword: Alzheimer's disease

Singapore's TauRx fails in PhIII on TAI

A major Phase III clinical trial of a tau inhibitor aggregation therapy by Singapore's TauRx failed to meet its primary endpoint, though the work showed an identified subgroup with a statistically significant benefit as a monotherapy.